The Role of Carbohydrate in Pharmaceuticals, Vaccines and Delivery Systems
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: closed (31 July 2024) | Viewed by 15977
Special Issue Editors
Interests: medicinal chemistry; carbohydrate chemistry; drug delivery
Interests: carbohydrate chemistry; vaccines; dendrimers
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue of Pharmaceutics has been dedicated to the role of carbohydrates as therapeutic agents, vaccines, and delivery systems. Recent trends in carbohydrate chemistry are indicating their importance in medicinal chemistry in terms of key players for the treatment of a wide range of diseases, including immuno-oncology. Glycans on their own can be therapeutic targets as well as being biocompatible and nontoxic carriers in nanoparticle (NP) platforms to deliver therapeutical agents to biological targets.. Nanoscale multimeric glycans such as glycoliposomes, glycopolymers, and glycodendrimers are being fully exploited as new-generation phramaceuticals. Glycoinhibitors of enzymes involved in lysosomal storage diseases also constitute therapeutic targets of great value.
Carbohydrates, with their stereochemical richness and varied functionalities, are considered valuable for the treatment of bacterial and viral infections and constitute potent glycopharmaceutics. The recent development of glycan microarrays has also been a determinant for the more subtle identification of cancer markers and better selection of anticarbohydrate antibodies and lectins. Antibody–drug conjugates (ADCs) are of therapeutic importance provided that their glycans are properly engineered.
Dr. Leila Mousavifar
Prof. Dr. René Roy
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- carbohydrates
- vaccines
- lectins
- antibodies
- galactins
- cancer therapy
- infectious diseases
- nanoparticles
- drug delivery
- polymeric scaffold
- drug delivery
- medicinal chemistry
- liposomes
- immune system
- drug uptake
- neoglycolipides
- Janus liposomes
- glycosylated NPs
- glycodendrimers
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.